GO:0015094 lead ion transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015094 describes the molecular function that enables the transfer of lead (Pb) ions across a membrane, as defined by QuickGO.
• Lead ion transport is a heavy-metal detoxification and homeostasis function that is often studied alongside zinc, cadmium, cobalt and nickel efflux systems.
• Transporters with this activity belong to membrane protein families that use ATP hydrolysis or chemiosmotic gradients to move metal ions against concentration gradients.
• Membrane-active molecular machines, including ion pumps and transporters, provide the mechanistic framework for understanding lead ion movement across lipid bilayers.
• Dysregulation of metal ion transport is relevant to cystic fibrosis lung disease, where altered ion transport and mucus obstruction drive pathology.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test whether candidate transporters causally mediate lead ion transport and toxicity.
Description
GO:0015094, lead ion transmembrane transporter activity, is a molecular function term in the Gene Ontology that describes the transfer of lead (Pb) ions from one side of a membrane to the other. This activity is part of the broader cellular toolkit for metal ion homeostasis and detoxification, and it is frequently annotated alongside transport activities for zinc, cadmium, cobalt and nickel. Because lead is a non-essential and toxic metal, proteins that catalyze its movement across membranes are central to understanding how cells handle heavy-metal stress. Researchers studying environmental toxicology, metal homeostasis and membrane transport often use this term to annotate genes and proteins that mediate lead efflux or uptake. The term is also relevant to comparative studies of ion pumps and secondary transporters, since the underlying mechanisms of ion translocation are shared across many metal substrates. In cystic fibrosis research, ion transport defects illustrate how membrane transport dysfunction can produce severe human disease, providing a conceptual parallel for studying lead transport proteins.
lead ion transmembrane transporter activity At A Glance
| GO ID | GO:0015094 |
|---|---|
| GO term | lead ion transmembrane transporter activity |
| Ontology | molecular_function |
| Definition | Enables the transfer of lead (Pb) ions from one side of a membrane to the other. |
| Synonym | zinc, cadmium, cobalt, nickel, lead-efflux ATPase activity |
| Major function | Translocation of lead ions across biological membranes |
| Related metal substrates | Zinc, cadmium, cobalt, nickel |
| Cellular context | Membrane transport and heavy-metal detoxification |
| Research relevance | Metal homeostasis, toxicology, membrane protein mechanism |
What Is GO:0015094?
According to the QuickGO definition, GO:0015094 enables the transfer of lead (Pb) ions from one side of a membrane to the other. In practical terms, a protein annotated with this term functions as a lead ion transporter: it binds Pb ions and moves them across a lipid bilayer, either out of the cell, into the cell, or between intracellular compartments. The synonym list includes zinc, cadmium, cobalt, nickel and lead-efflux ATPase activity, indicating that some transporters annotated to this term have broad metal specificity and can use ATP hydrolysis to drive lead efflux. This activity is a molecular function, not a biological process or cellular component, so it describes what a protein does rather than where or when it acts.
Why Is lead ion transmembrane transporter activity Important in Cell Biology?
Lead ion transmembrane transporter activity matters because lead is a toxic heavy metal with no known beneficial biological role, and the proteins that move lead across membranes determine how cells accumulate, distribute and eliminate it. Understanding this activity helps researchers annotate genomes, interpret metal-resistance phenotypes and design experiments on heavy-metal detoxification. Because many transporters annotated to GO:0015094 also handle zinc, cadmium, cobalt and nickel, this term sits at the intersection of metal homeostasis and environmental toxicology. In addition, membrane transport proteins are tractable drug targets and are central to diseases of ion transport such as cystic fibrosis, where mutations in ion channels cause misfunction and guide therapy.
• Lead is a non-essential toxic metal, so transporters with GO:0015094 activity are directly relevant to heavy-metal detoxification.
• The term groups ATP-driven and gradient-driven metal efflux systems, linking lead transport to broader metal homeostasis.
• Many annotated transporters also recognize zinc, cadmium, cobalt and nickel, making this term useful for cross-metal studies.
• Membrane-active molecular machines provide mechanistic models for how lead ions are translocated across bilayers.
• Ion transport dysfunction is a proven disease mechanism in cystic fibrosis, illustrating the clinical importance of membrane transport proteins.
• Cystic fibrosis research has produced mutation-specific therapies, a paradigm that can inspire functional studies of lead transport variants.
• Metal transport proteins are candidate biomarkers and targets in environmental and occupational lead exposure research.
• CRISPR-based models allow causal testing of candidate lead transporter genes in human cell lines.
• Bioinformatics and library screening can identify new genes annotated to GO:0015094 across genomes.
• Understanding lead transport supports risk assessment and bioremediation strategies.
What Happens During lead ion transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs the lead ion.
The transport cycle begins when a membrane-embedded transporter binds a lead (Pb) ion from the aqueous phase on one side of the membrane. Binding sites typically use conserved cysteine, histidine or acidic residues to coordinate the metal ion, a strategy shared with transporters of zinc, cadmium, cobalt and nickel. This step determines substrate specificity and is the basis for the broad metal recognition implied by the synonym list of GO:0015094.
Conformational change and translocation
In simple terms: The protein changes shape to push the ion through the membrane.
After binding, the transporter undergoes conformational changes that move the lead ion across the lipid bilayer. Membrane-active molecular machines use alternating access mechanisms, in which the substrate-binding site switches between outward-facing and inward-facing states. This step is energetically coupled to ATP hydrolysis in ATPase-type transporters or to an existing ion gradient in secondary transporters.
Energy coupling and driving force
In simple terms: The cell pays energy to move lead against its gradient.
Lead efflux often requires energy because the ion must be moved against its concentration gradient. The synonym lead-efflux ATPase activity indicates that some transporters annotated to GO:0015094 use ATP hydrolysis to power transport. Other family members may exploit chemiosmotic gradients, a general principle of membrane bioenergetics established in studies of ion-translocating proteins.
Release and reset
In simple terms: The ion is released and the transporter resets for another round.
Once the lead ion reaches the opposite side of the membrane, it is released into the aqueous phase, and the transporter returns to its initial conformation to complete the cycle. This alternating access cycle is a hallmark of membrane transport proteins and is required for continuous detoxification. The reset step ensures that the transporter can process multiple ions, which is important for maintaining metal homeostasis under chronic exposure.
Integration with cellular metal homeostasis
In simple terms: Lead transport is part of the cell's wider metal-handling network.
Lead ion transport does not occur in isolation; it is integrated with pathways that handle essential metals such as zinc, cobalt and nickel. Because the same transporters can recognize multiple metals, changes in lead transport can influence the distribution of other metal ions and vice versa. This crosstalk is a key reason why GO:0015094 is studied in the context of metal homeostasis and toxicology.
Key Genes Involved in GO:0015094 lead ion transmembrane transporter activity
The following genes and protein families are representative of the metal transport systems that carry or are annotated with lead ion transmembrane transporter activity and related heavy-metal efflux functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ZntA | P-type ATPase metal efflux pump | Model for lead, zinc and cadmium efflux ATPase activity |
| CadA | P-type ATPase cadmium/lead efflux | Prototype for heavy-metal ATPase mechanism |
| CopA | Copper-transporting P-type ATPase | Comparative model for metal ATPase structure and function |
| CzcA | Cobalt-zinc-cadmium resistance transporter | Broad metal specificity relevant to GO:0015094 synonym list |
| ZIP family | Zinc and metal uptake transporters | Candidate uptake route for toxic metals |
| NRAMP family | Divalent metal ion transporters | Metal homeostasis and host-pathogen metal transport |
| CDF family | Cation diffusion facilitators | Secondary metal efflux systems |
| HMA family | Heavy-metal ATPases | ATP-driven lead and cadmium efflux |
| ATP7A | Copper-transporting ATPase | Human metal ATPase disease model |
| ATP7B | Copper-transporting ATPase | Human metal ATPase disease model |
| SLC30A family | Zinc transporters | Membrane metal transport in human cells |
| SLC39A family | Zinc and metal uptake transporters | Metal uptake and toxicity studies |
| CFTR | Chloride and bicarbonate channel | Ion transport disease paradigm in cystic fibrosis |
| MTF1 | Metal-responsive transcription factor | Regulation of metal homeostasis genes |
| Ferroportin | Iron exporter | Comparative membrane metal export |
| Bacteriorhodopsin | Light-driven proton pump | Model membrane transport protein |
| Methanogen membrane proteins | Ion and substrate transport | Microbial membrane transport context |
How Is lead ion transmembrane transporter activity Regulated?
Lead ion transmembrane transporter activity is regulated at multiple levels. Transcriptional control by metal-responsive factors adjusts transporter abundance in response to metal exposure, a general principle of metal homeostasis. Post-translational regulation, including phosphorylation and protein-protein interactions, can modulate transporter activity and trafficking. In addition, membrane composition and electrochemical gradients influence the driving force for transport, as established for membrane-active molecular machines. Because many transporters annotated to GO:0015094 also handle zinc, cadmium, cobalt and nickel, their regulation is embedded in a broader metal-sensing network. In human disease contexts such as cystic fibrosis, ion transport is further regulated by channel trafficking and mutation-specific defects, illustrating how transport activity can be controlled at the level of protein biogenesis and stability.
lead ion transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ZntA | Heavy-metal resistance and detoxification | Bacterial knockout and complementation |
| CadA | Cadmium and lead efflux | Heterologous expression in metal-sensitive strains |
| ATP7A | Copper transport disorders | Human cell knock-in of patient variants |
| ATP7B | Copper transport disorders | Hepatocyte-like cell models |
| CFTR | Cystic fibrosis ion transport defect | Knockout and point-mutation human airway cells |
Heavy-metal toxicity and lead exposure
Lead is a toxic metal, and proteins with lead ion transmembrane transporter activity determine how cells take up, distribute and eliminate it. Variation in transporter expression or function can therefore influence susceptibility to lead toxicity. Studying these transporters in cell models helps link molecular transport activity to cellular metal burden.
Cystic fibrosis as an ion transport disease paradigm
Cystic fibrosis is caused by mutations in the CFTR ion channel and is a leading example of how defective membrane transport produces human disease. Molecular studies show how CFTR mutations lead to misfunction and guide therapy, providing a template for functional analysis of transport proteins. Clinical trials of CFTR modulators demonstrate that correcting ion transport defects can produce therapeutic benefit.
Metal homeostasis and neurodegeneration
Disrupted metal ion homeostasis is increasingly recognized in neurodegenerative and metabolic conditions, although direct evidence for lead-specific transporters in these diseases remains an active research area. Comparative studies of metal ATPases and transporters provide a framework for testing whether lead transport contributes to neuronal metal imbalance.
Environmental and occupational health
Environmental and occupational lead exposure remains a global health concern, and understanding transporter-mediated lead handling is relevant to risk assessment. Cell-based models expressing candidate transporters can be used to test how genetic variation affects lead accumulation.
From lead ion transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for lead efflux? | CRISPR knockout cell line |
| Does a specific residue mediate lead binding? | Point-mutation knock-in |
| Can a tagged transporter be localized in live cells? | Tagged knock-in |
| Does overexpression increase lead resistance? | Overexpression cell line |
| Which genes are annotated to GO:0015094? | Bioinformatics and CRISPR library screening |
| Does a human variant alter transport activity? | Patient-derived variant knock-in |
How to Study the lead ion transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Metal sensitivity assay | Cell growth under lead exposure | Testing transporter-mediated resistance |
| ATPase activity assay | ATP hydrolysis by transporters | Measuring lead-efflux ATPase activity |
| RNA-seq | Gene expression changes after metal exposure | Identifying metal-responsive transporters |
| CRISPR library screening | Genes required for metal resistance | Discovery of new GO:0015094 candidates |
| Fluorescent metal imaging | Intracellular metal levels | Live-cell transport studies |
| Proteomics | Transporter abundance and interactions | Membrane protein characterization |
| Structural biology | Metal-binding site geometry | Mechanistic studies of transport |
| Complementation assay | Restoration of metal resistance | Functional validation of candidate genes |
Metal sensitivity and transport assays
Growth or survival assays in the presence of lead salts can measure whether a candidate transporter confers resistance or sensitivity. These assays are widely used for bacterial metal efflux systems and can be adapted to human cell lines. Complementation of metal-sensitive strains is a classic approach to test transporter function.
Membrane protein biochemistry
Purification and reconstitution of membrane transporters allow direct measurement of ion translocation and ATP hydrolysis. Membrane-active molecular machines are studied using such approaches, which can be applied to lead transporters. Structural methods provide insight into metal-binding sites and conformational cycles.
Transcriptomics and metal-responsive gene expression
RNA-seq can identify genes whose expression changes after lead exposure, revealing candidate transporters and regulators. Comparing wild-type and knockout cells helps distinguish direct transport effects from downstream stress responses.
Imaging and metal detection
Fluorescent metal sensors and imaging can track intracellular metal levels in live cells. These methods complement biochemical transport assays and help localize transporter activity to specific membranes. In cystic fibrosis research, imaging of ion transport and mucus properties illustrates how transport function can be visualized in disease models.
How CRISPR Can Be Used to Study GO:0015094 lead ion transmembrane transporter activity
Knockout
CRISPR knockout of a candidate transporter gene can test whether the gene is required for lead efflux or lead resistance. Loss-of-function models are compared with wild-type cells in metal sensitivity assays. This approach is widely used for bacterial and human metal transport genes.
Point Mutation
Point mutations in predicted metal-binding residues can test their role in lead ion coordination and transport. This strategy mirrors functional studies of disease-causing mutations in ion transport proteins such as CFTR. Point-mutation models help distinguish transport defects from protein folding or trafficking defects.
Knock-in
Knock-in of tagged or patient-derived variants allows localization and functional analysis of transporters in a native genomic context. Tagged knock-in is useful for imaging transporter trafficking and membrane localization. Variant knock-in can reveal how human polymorphisms affect lead transport.
Overexpression
Overexpression of a candidate transporter can increase lead efflux or uptake and is a direct test of sufficiency. Overexpression models are useful when knockout alone does not produce a measurable phenotype. They also support biochemical purification of the transporter for mechanistic studies.
How EDITGENE Supports lead ion transmembrane transporter activity Research
Researchers studying lead ion transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in lead transport, metal resistance or toxicity. Establishing causality requires precise genetic models that can remove, modify or add the gene of interest in a controlled cellular background. EDITGENE provides end-to-end CRISPR services to generate such models and to interpret the resulting phenotypes with bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for lead ion transmembrane transporter activity research.
Frequently Asked Questions About lead ion transmembrane transporter activity
What is GO:0015094?
GO:0015094 is the Gene Ontology molecular function term for lead ion transmembrane transporter activity, defined as enabling the transfer of lead (Pb) ions from one side of a membrane to the other.
What is lead ion transmembrane transporter activity?
It is the activity of a membrane protein that moves lead ions across a lipid bilayer, often as part of heavy-metal detoxification or homeostasis.
What genes are involved in lead ion transmembrane transporter activity?
Genes encoding P-type ATPases, cation diffusion facilitators and other metal transporters, such as ZntA, CadA and HMA-family ATPases, are representative examples.
What are the synonyms of GO:0015094?
The QuickGO synonym is zinc, cadmium, cobalt, nickel, lead-efflux ATPase activity, reflecting the broad metal specificity of some annotated transporters.
Why is lead ion transport important?
Lead is a toxic metal, and transporters determine how cells accumulate and eliminate it, making this activity relevant to toxicology and metal homeostasis.
How can I study lead ion transmembrane transporter activity?
Common approaches include metal sensitivity assays, ATPase activity assays, RNA-seq, fluorescent metal imaging and CRISPR knockout or overexpression models.
Which diseases are linked to ion transport defects?
Cystic fibrosis is a well-characterized ion transport disease caused by CFTR mutations, providing a paradigm for transport-related disease research.
Can CRISPR be used to study lead transporters?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate lead transporter genes.
What is the role of ATP in lead efflux?
Some transporters annotated to GO:0015094 use ATP hydrolysis to drive lead efflux, as indicated by the lead-efflux ATPase activity synonym.
How does EDITGENE support GO:0015094 research?
EDITGENE provides knockout, point-mutation, knock-in, overexpression, library screening and bioinformatics services to study lead ion transport genes.
Conclusion
GO:0015094, lead ion transmembrane transporter activity, defines the molecular function that moves toxic lead ions across biological membranes. It connects membrane protein mechanism, heavy-metal homeostasis and environmental toxicology, and it is studied using biochemical, imaging and CRISPR-based approaches. Because ion transport defects are clinically important, as shown by cystic fibrosis research, understanding lead transport proteins may inform both basic biology and translational studies. Precise CRISPR models and bioinformatics pipelines are essential tools for establishing causal roles of candidate transporters in lead handling.
References
- 1. Shteinberg M et al.. 2021. Cystic fibrosis.. Lancet 397(10290):2195-2211 PMID: 34090606
- 2. Fajac I et al.. 2023. Cystic fibrosis.. Presse Med 52(3):104169 PMID: 37516246
- 3. Farinha CM et al.. 2022. Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.. Biosci Rep 42(7) PMID: 35707985
- 4. Lanyi JK. 1999. Bacteriorhodopsin.. Int Rev Cytol 187:161-202 PMID: 10212980
- 5. Shen J et al.. 2022. Membrane-Active Molecular Machines.. Acc Chem Res 55(8):1148-1159 PMID: 35345880
- 6. Blaut M. 1994. Metabolism of methanogens.. Antonie Van Leeuwenhoek 66(1-3):187-208 PMID: 7747931
- 7. Uluer AZ et al.. 2023. Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.. Lancet Respir Med 11(6):550-562 PMID: 36842446
